Pharma Industry Continues Building Open Innovation Models
The Nature Biotechnology website reports that seven large pharma companies and a biotech firm, Alnylam, have formed a collaboration with the World Intellectual Property Organisation (WIPO) to establish WIPO Re:Search. This open innovation initiative lines up United Nations agency WIPO of Geneva with Washington, DC–based BIO Ventures for Global Health, the US National Institutes of Health (NIH), drug companies and academic institutions in an effort to share intellectual property (IP) and resources that can speed drug discovery.
Click here to read the full article.
